200,000+ products from a single source!
sales@angenechem.com
Home > Quinoline > 129075-56-5
129075-56-5 | 5-Methyl-3,4-dihydroisoquinolin-1(2H)-one
CAS No: 129075-56-5 Catalog No: AG000YT7 MDL No:MFCD00890474
Product Description
Catalog Number:
AG000YT7
Chemical Name:
5-Methyl-3,4-dihydroisoquinolin-1(2H)-one
CAS Number:
129075-56-5
Molecular Formula:
C10H11NO
Molecular Weight:
161.2004
MDL Number:
MFCD00890474
IUPAC Name:
5-methyl-3,4-dihydro-2H-isoquinolin-1-one
InChI:
InChI=1S/C10H11NO/c1-7-3-2-4-9-8(7)5-6-11-10(9)12/h2-4H,5-6H2,1H3,(H,11,12)
InChI Key:
RLLZPXDJYADIEU-UHFFFAOYSA-N
SMILES:
O=C1NCCc2c1cccc2C
Properties
Complexity:
190
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
161.084g/mol
Formal Charge:
0
Heavy Atom Count:
12
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
161.204g/mol
Monoisotopic Mass:
161.084g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
29.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.6
Literature
| Title | Journal |
|---|---|
| Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia. | The Journal of pharmacology and experimental therapeutics 20080901 |
| MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic beta-cells. | Diabetes 20060301 |
| Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase. | Journal of medicinal chemistry 20041021 |
| Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression. | European journal of biochemistry 20030101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.